In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy.

Could a lower threshold for radon levels in Canadian homes protect more people from getting lung cancer? Some researchers say Canada is overdue for an evidence-backed rethink in light of emerging ...

A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...

Lung cancer cells are able to take advantage of a person’s immune system, specifically T cells, to protect the tumor, according to new research recently published in Cancer Immunology Research.

Lung cancer is now the leading cause of cancer deaths in the United States, claiming more lives than several other major cancers combined.

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...

Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Lung cancer remains the world’s deadliest cancer, and cigarette smoke is its chief culprit. Chemicals in tobacco, such as polycyclic aromatic hydrocarbons (PAHs), damage DNA and trigger the mutations ...

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- The Lung Cancer Research Foundation® (LCRF) awarded its annual 2025 Scientific Grant Program awards, funding another $1.65 million in new research. This year's ...